Return to search results
💡 Advanced Search Tip
Search by organization or tag to find related datasets
Patent AT-E401107-T1: [Translated] INTRADUCTAL TREATMENT OF BREAST LESIONS COMPRISING THERAPEUTIC AND DIAGNOSTIC AGENTS
The present invention relates to an apparatus and method for administering a radioactive tracer dye and an inhibitor compound into a breast duct of the breast and imaging the breast for breast lesions. The radioactive tracer dye may be Tc-99m sestamibi and the inhibitor compound may inhibit a P-glycoprotein pump in tumor cells. When the inhibitor compound inhibits the P-glycoprotein pump in tumor cells, the radioactive tracer dye may effectively accumulate in tumor cells and improve the sensitivity of nuclear imaging of breast lesions.
Complete Metadata
| bureauCode |
[ "009:25" ] |
|---|---|
| identifier | https://healthdata.gov/api/views/ijvg-kay8 |
| issued | 2025-09-05 |
| landingPage | https://healthdata.gov/d/ijvg-kay8 |
| programCode |
[ "009:066" ] |
| theme |
[ "NIH" ] |
